Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Alliance Grants

University of Guelph

$21,770.00

Exploring the effects of a Canadian grown oilseed, Camelina sativa, with or without added DHA and EPA on the reactivity of horses

FY 2024-25

Summary
The most common cause of injury in the equine industry is caused by startled horses. Reducing reactivity could help to minimize the prevalence of equine-related injuries and fatalities in Canada and help reduce our public health care costs. There is a lack of data investigating the effects of fatty acids from oil supplements on modifying behaviour. Despite a lack of data, supplements marketed for calming are among the most popular equine supplements with horse owners. Tryptophan (Trp), a precursor of serotonin, is an essential amino acid that needs to be supplied in the diet of the horse. When bound to transport proteins in the blood, Trp cannot pass the blood-brain barrier and be converted to serotonin. Supplementation of n3 FA may increase competition between Trp and FA for transport proteins in the blood, allowing more Trp to be available for conversion to serotonin in the brain. To our knowledge, whether the n3 FA should be supplied as alpha-linolenic acid (ALA), docosahexaenoic acid (DHA) and/or eicosapentaenoic acid (EPA) has not been investigated in horses. Supplementation of n3 FA in horses will alter blood FA profile and Trp concentrations in a dose-response manner and will reduce reactivity Further, supplementation with both a C18 n3 FA (ALA) and C22 and C20 n3 fatty acids (DHA and EPA) will be advantageous in contrast to supplementation with ALA alone. To address this, we will supplement three groups of 8 horses with: 1) no oil, 2) camelina oil, or 3) camelina oil plus DHA+EPA and feed them these supplements in addition to a base of ad libitum hay for 6 weeks and horses will have behaviour tests (novel object test) while HR is measured continuously. After the behaviour tests, blood will be sampled to measure cortisol, free fatty acids, amino acids (Trp), and serum biochemistry. Data from this study will allow us to understand if camelina oil and camelina oil enriched in DHA and EPA can help to reduce reactivity in young horses. We will disseminate knowledge of this trial through scientific and lay communications to professionals and horse owners, respectively.
Program
Alliance Grants
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
581753-2023
Name nom
Shoveller, Anna AK
Department département
Animal Biosciences
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2023
Award amount
21770
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5511
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal nutrition and husbandry
Research subject fr
Nutrition et élevage des animaux
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Exploring the effects of a Canadian grown oilseed, Camelina sativa, with or without added DHA and EPA on the reactivity of horses
Keywords
camelina sativa; docosahexaenoic acid; eicosapentaenoic acid; equine; reactivity
Application summary
The most common cause of injury in the equine industry is caused by startled horses. Reducing reactivity could help to minimize the prevalence of equine-related injuries and fatalities in Canada and help reduce our public health care costs. There is a lack of data investigating the effects of fatty acids from oil supplements on modifying behaviour. Despite a lack of data, supplements marketed for calming are among the most popular equine supplements with horse owners. Tryptophan (Trp), a precursor of serotonin, is an essential amino acid that needs to be supplied in the diet of the horse. When bound to transport proteins in the blood, Trp cannot pass the blood-brain barrier and be converted to serotonin. Supplementation of n3 FA may increase competition between Trp and FA for transport proteins in the blood, allowing more Trp to be available for conversion to serotonin in the brain. To our knowledge, whether the n3 FA should be supplied as alpha-linolenic acid (ALA), docosahexaenoic acid (DHA) and/or eicosapentaenoic acid (EPA) has not been investigated in horses. Supplementation of n3 FA in horses will alter blood FA profile and Trp concentrations in a dose-response manner and will reduce reactivity Further, supplementation with both a C18 n3 FA (ALA) and C22 and C20 n3 fatty acids (DHA and EPA) will be advantageous in contrast to supplementation with ALA alone. To address this, we will supplement three groups of 8 horses with: 1) no oil, 2) camelina oil, or 3) camelina oil plus DHA+EPA and feed them these supplements in addition to a base of ad libitum hay for 6 weeks and horses will have behaviour tests (novel object test) while HR is measured continuously. After the behaviour tests, blood will be sampled to measure cortisol, free fatty acids, amino acids (Trp), and serum biochemistry. Data from this study will allow us to understand if camelina oil and camelina oil enriched in DHA and EPA can help to reduce reactivity in young horses. We will disseminate knowledge of this trial through scientific and lay communications to professionals and horse owners, respectively.